Apollo Therapeutics
Richard Brown currently serves as the VP & Global Program Leader at Apollo Therapeutics since January 2022, bringing with him extensive experience in project leadership from their previous roles at PsiOxus Therapeutics Ltd, Amgen, UCB, Oxford Glycosciences, Yamanouchi Research Institute, and University College London. With a PhD in Biochemistry from the Institute of Cancer Research and a degree in Biochemistry from the University of Bath, Richard's professional journey has been marked by a commitment to excellence in scientific research and project management.
Apollo Therapeutics
1 followers
Apollo Therapeutics provides funding & drug discovery expertise accelerating the best of British academic research to the clinic.